Home NDC 0049-3920-83 Geodon
Product NDC 0049-3920
Requested package NDC 0049-3920-83
11-digit product format 000493920
Labeler code 0049
Product ID 0049-3920_234488e0-550f-4c40-bd70-d98d051371b9
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ziprasidone mesylate
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAMUSCULAR
Labeler Roerig
Application NDA020919
Marketing category NDA
Marketing start 2003-12-23
Marketing end 0000-00-00
Substance ZIPRASIDONE MESYLATE
Active strength 20 mg/mL
Pharmacologic classes Atypical Antipsychotic [EPC]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 2 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0049-3920 0049-3920-83 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0049-3920 0049-3920-83 D Discontinued by firm excluded / ndc_excluded.zip f5e01cc5f278…a2eaf40c39c3…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020919-001 GEODON ZIPRASIDONE MESYLATE EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N020919-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 84e616aacf4f…2026-08-18 06:07:40 2026-07 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR RLD, RS 2002-06-21 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR RLD, RS 2002-06-21 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR RLD, RS 2002-06-21 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR RLD, RS 2002-06-21 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 f41ea6bd6efb…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0049-3920-01 Geodon 1 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 1 48 0049-3920-10 Geodon 10 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 10 48 0049-3920-20 Geodon 1 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 1 48 0049-3920-83 Geodon 10 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 10 48
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ZIPRASIDONE HYDROCHLORIDE ACTIVE INGREDIENT 216X081ORU GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 ZIPRASIDONE MESYLATE ACTIVE INGREDIENT 3X6SAX83JZ GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 ZIPRASIDONE ACTIVE MOIETY 6UKA5VEJ6X GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 LACTOSE INACTIVE INGREDIENT J2B2A4N98G GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 METHANESULFONIC ACID INACTIVE INGREDIENT 12EH9M7279 GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 SULFOBUTYLETHER .BETA.-CYCLODEXTRIN INACTIVE INGREDIENT 2PP9364507 GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 ZIPRASIDONE MESYLATE ACTIVE INGREDIENT 3X6SAX83JZ GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [TYA PHARMACEUTICALS] 2 ZIPRASIDONE ACTIVE MOIETY 6UKA5VEJ6X GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [TYA PHARMACEUTICALS] 2 METHANESULFONIC ACID INACTIVE INGREDIENT 12EH9M7279 GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [TYA PHARMACEUTICALS] 2 SULFOBUTYLETHER .BETA.-CYCLODEXTRIN INACTIVE INGREDIENT 2PP9364507 GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [TYA PHARMACEUTICALS] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0049-3920 GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION GEODON (ZIPRASIDONE) CAPSULE [ROERIG] 46 Legacy NDC, 4 package rows 20250129_8326928a-2cb6-4f7f-9712-03a425a14c37.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0049-3920-83 00049392083 10 VIAL, SINGLE-DOSE in 1 CARTON (0049-3920-83) > 1 mL in 1 VIAL, SINGLE-DOSE (0049-3920-20) 2003-12-23 0000-00-00 No No Current